Evidence map›Paper›PMID 31096909›Full record

ArticleBMC microbiology2019

Gut microbial beta-glucuronidase and glycerol/diol dehydratase activity contribute to dietary heterocyclic amine biotransformation.

Jianbo Zhang, Christophe Lacroix, Esther Wortmann, Hans-Joachim Ruscheweyh, Shinichi Sunagawa, Shana J Sturla, Clarissa Schwab

Open access · goldAbstract read
In one paragraph

Article in BMC microbiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 1 synthesis or guideline pooled it, 73 citations in OpenAlex.

  1. Pooled it
  2. Synergistic inhibition ofFrontiers in microbiology · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Microbiome research reports · 2024
    Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Genetic heterogeneity of colorectal cancer and the microbiome.World journal of gastrointestinal oncology · 2023
    Review
  19. Article
  20. Microbiota of the gastrointestinal tract: Friend or foe?World journal of gastroenterology · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 2 countries.

Jianbo ZhangDepartment of Health Sciences and Technology, ETH Zürich, Zürich, Switzerland.
Christophe LacroixDepartment of Health Sciences and Technology, ETH Zürich, Zürich, Switzerland.
Esther WortmannDepartment of Health Sciences and Technology, ETH Zürich, Zürich, Switzerland.
Hans-Joachim RuscheweyhDepartment of Biology, ETH Zürich, Zürich, Switzerland.
Shinichi SunagawaDepartment of Biology, ETH Zürich, Zürich, Switzerland.
Shana J SturlaDepartment of Health Sciences and Technology, ETH Zürich, Zürich, Switzerland.
Clarissa SchwabDepartment of Health Sciences and Technology, ETH Zürich, Zürich, Switzerland. clarissa.schwab@hest.ethz.ch.ORCID 0000-0002-5443-1602
ETH Zurich · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundConsuming red and processed meat has been associated with an increased risk of colorectal cancer (CRC), which is partly attributed to exposure to carcinogens such as heterocyclic amines (HCA) formed during cooking and preservation processes. The interaction of gut microbes and HCA can result in altered bioactivities and it has been shown previously that human gut microbiota can transform mutagenic HCA to a glycerol conjugate with reduced mutagenic potential. However, the major form of HCA in the colon are glucuronides (HCA-G) and it is not known whether these metabolites, via stepwise microbial hydrolysis and acrolein conjugation, are viable precursors for glycerol conjugated metabolites. We hypothesized that such a process could be concurrently catalyzed by bacterial beta-glucuronidase (B-GUS) and glycerol/diol dehydratase (GDH) activity. We therefore investigated how the HCA-G PhIP-N2-β-D-glucuronide (PhIP-G), a representative liver metabolite of PhIP (2-Amino-1-methyl-6-phenylimidazo [4,5-b] pyridine), which is the most abundant carcinogenic HCA in well-cooked meat, is transformed by enzymatic activity of human gut microbial representatives of the phyla Firmicutes, Bacteroidetes, and Proteobacteria.

resultsWe employed a combination of growth and enzymatic assays, and a bioanalysis approach combined with metagenomics. B-GUS of Faecalibacterium prausnitzii converted PhIP-G to PhIP and GDH of Flavonifractor plautii, Blautia obeum, Eubacterium hallii, and Lactobacillus reuteri converted PhIP to PhIP-M1 in the presence of glycerol. In addition, B-GUS- and GDH-positive bacteria cooperatively converted PhIP-G to PhIP-M1. A screen of genes encoding B-GUS and GDH was performed for fecal microbiome data from healthy individuals (n = 103) and from CRC patients (n = 53), which revealed a decrease in abundance of taxa with confirmed GDH and HCA transformation activity in CRC patients.

conclusionsThis study for the first time demonstrates that gut microbes mediate the stepwise transformation of PhIP-G to PhIP-M1 via the intermediate production of PhIP. Findings from this study suggest that targeted manipulation with gut microbes bearing specific functions, or dietary glycerol supplementation might modify gut microbial activity to reduce HCA-induced CRC risk.

Indexed as

DietGastrointestinal MicrobiomeBacillotaBacteriaBacteroidetesBiotransformationCarcinogensColorectal NeoplasmsFecesGlucuronidaseGlucuronidesGlycerolHumansImidazolesMeatMetagenomics2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridineCarcinogensGlucuronidaseGlucuronidesGlycerolImidazolesPropanediol DehydrataseEubacterium halliiFaecalibacterium prausnitziiGlycerol/diol dehydrataseHeterocyclic amines (HCA)Reuterinβ-Glucuronidase

Identifiers

PMID31096909
PMCPMC6524314
OpenAlexW2944852121

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.